1 |
Zhan, C., Gu, B., Xie, C., Li, J., Liu, Y. and Lu, W. (2010) Cyclic RGD conjugated poly (ethylene glycol)-co-poly (lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J. Control. Release 143, 136-142.
DOI
|
2 |
Zhao, D., Gong, T., Fu, Y., Nie, Y., He, L. L., Liu, J. and Zhang, Z. R. (2008) Lyophilized Cheliensisin A submicron emulsion for intravenous injection: characterization, in vitro and in vivo antitumor effect. Int. J. Pharm. 357, 139-147.
DOI
|
3 |
Zhao, P., Wang, H., Yu, M., Cao, S., Zhang, F., Chang, J. and Niu, R. (2010) Paclitaxel-loaded, folic-acid-targeted and TAT-peptideconjugated polymeric liposomes: in vitro and in vivo evaluation. Pharm. Res. 27, 1914-1926.
DOI
|
4 |
Zhao, P., Wang, H., Yu, M., Liao, Z., Wang, X., Zhang, F., Ji, W., Wu, B., Han, J., Zhang, H., Wang, H., Chang, J. and Niu, R. (2012) Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 81, 248-256.
DOI
|
5 |
Baek, J. S., Shin, S. C. and Cho, C. W. (2012) Effect of lipid on physicochemical properties of solid lipid nanoparticle of paclitaxel. Int. J. Pharm. Investig. 42, 279-283.
DOI
|
6 |
Battistini, F. D., Flores-Martin, J., Olivera, M. E., Genti-Raimondi, S. and Manzo, R. H. (2014) Hyaluronan as drug carrier. The in vitro efficacy and selectivity of Hyaluronan-Doxorubicin complexes to affect the viability of overexpressing CD44 receptor cells. Eur. J. Pharm. Sci. 65, 122-129.
DOI
|
7 |
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jerôme, C., Marchand-Brynaert, J., Feron, O. and Preat, V. (2009) Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. J. Control. Release 140, 166-173.
DOI
|
8 |
Davis, M. E., Chen, Z. G. and Shin, D. M. (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7, 771-782.
DOI
|
9 |
Fang, J., Nakamura, H. and Maeda, H. (2011) The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 63, 136-151.
DOI
|
10 |
Journo-Gershfeld, G., Kapp, D., Shamay, Y., Kopeček, J. and David, A. (2012) Hyaluronan oligomers-HPMA copolymer conjugates for targeting paclitaxel to CD44-overexpressing ovarian carcinoma. Pharm. Res. 29, 1121-1133.
DOI
|
11 |
Kim, J. E. and Park, Y. J. (2016) High paclitaxel-loaded and tumor cell-targeting hyaluronan-coated nanoemulsions. Colloids Surf. B Biointerfaces. [Epub ahead of print].
|
12 |
Kirtane, A. R., Narayan, P., Liu, G. and Panyam, J. (2016) Polymersurfactant nanoparticles for improving oral bioavailability of doxorubicin. Int. J. Pharm. Investig. [Epub ahead of print].
|
13 |
Liebmann, J., Cook, J. A. and Mitchell, J. B. (1993) Cremophor EL, solvent for paclitaxel, and toxicity. Lancet 342, 1428.
|
14 |
Liu, D., Liu, F., Liu, Z., Wang, L. and Zhang, N. (2011a) Tumor specific delivery therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody. Mol. Pharm. 8, 2291-2301.
DOI
|
15 |
Liu, D., Liu, Z., Wang, L., Zhang, C. and Zhang, N. (2011b) Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf. B Biointerfaces 85, 262-269.
DOI
|
16 |
Liu, P., Situ, J. Q., Li, W. S., Shan, C. L., You, J., Yuan, H., Hu, F. Q. and Du, Y. Z. (2015) High tolerated paclitaxel nano-formulation delivered by poly (lactic-co-glycolic acid)-g-dextran micelles to efficient cancer therapy. Nanomedicine 11, 855-866.
DOI
|
17 |
Matsubara, Y., Katoh, S., Taniguchi, H., Oka, M., Kadota, J. and Kohno, S. (2000) Expression of CD44 variants in lung cancer and its relationship to hyaluronan binding. J. Int. Med. Res. 28, 78-90.
DOI
|
18 |
Mercê, A. L., Marques Carrera, L. C., Santos Romanholi, L. K. and Lobo Recio, M. A. (2002) Aqueous and solid complexes of iron (III) with hyaluronic acid: potentiometric titrations and infrared spectroscopy studies. J. Inorg. Biochem. 89, 212-218.
DOI
|
19 |
Mizrahy, S., Raz, S. R., Hasgaard, M., Liu, H., Soffer-Tsur, N., Cohen, K., Dvash, R., Landsman-Milo, D., Bremer, M. G., Moghimi, S. M. and Peer, D. (2011) Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response. J. Control. Release 156, 231-238.
DOI
|
20 |
Orr, G. A., Verdier-Pinard, P., McDaid, H. and Horwitz, S. B. (2003) Mechanisms of Taxol resistance related to microtubules. Oncogene 22, 7280-7295.
DOI
|
21 |
Othman, T., Goto, S., Lee, J. B., Taimura, A., Matsumoto, T. and Kosaka, M. (2001) Hyperthermic enhancement of the apoptotic and antiproliferative activities of paclitaxel. Pharmacology 62, 208-212.
DOI
|
22 |
Park, J. H., Cho, H. J., Yoon, H. Y., Yoon, I. S., Ko, S. H., Shim, J. S., Cho, J. H., Park, J. H., Kim, K., Kwon, I. C. and Kim, D. D. (2014) Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. J. Control. Release 174, 98-108.
DOI
|
23 |
Sim, T., Lim, C., Hoang, N. H., Joo, H., Lee, J. W., Kim, D.-w., Lee, E. S., Youn, Y. S., Kim, J. O. and Oh, K. T. (2016) Nanomedicines for oral administration based on diverse nanoplatform. Int. J. Pharm. Investig. 46, 351-362.
DOI
|
24 |
Singla, A. K., Garg, A. and Aggarwal, D. (2002) Paclitaxel and its formulations. Int. J. Pharm. 235, 179-192.
DOI
|
25 |
Xin, D., Wang, Y. and Xiang, J. (2010) The use of amino acid linkers in the conjugation of paclitaxel with hyaluronic acid as drug delivery system: synthesis, self-assembled property, drug release, and in vitro efficiency. Pharm. Res. 27, 380-389.
DOI
|
26 |
Xiong, Y., Zhao, Y., Miao, L., Lin, C. M. and Huang, L. (2016) Codelivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer. J. Control. Release. 244, 63-73.
DOI
|
27 |
Yang, X. Y., Li, Y. X., Li, M., Zhang, L., Feng, L. X. and Zhang, N. (2013) Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Cancer Lett. 334, 338-345.
DOI
|